Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
about
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyRuxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
P2860
Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@ast
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@en
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@nl
type
label
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@ast
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@en
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@nl
prefLabel
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@ast
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@en
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@nl
P2860
P3181
P356
P1476
Spotlight on talimogene laherp ...... ns in the skin and lymph nodes
@en
P2093
Marlana Orloff
P2860
P3181
P356
10.2147/OV.S99532
P407
P577
2016-10-04T00:00:00Z